Anheuser-Busch InBev (BUD): Q1 2026 Earnings Beat Highlights Premiumization Strength
Key Takeaways
- Anheuser-Busch InBev reported Q1 2026 revenue of $15.267 billion, up 5.8% organically from $13.628 billion in Q1 2025, beating consensus estimates around $14.7 billion.
- Underlying EPS rose 20.8% to $0.97 from $0.81 year-over-year, surpassing analyst expectations of approximately $0.90-$0.91.
- Beer volumes grew 1.2% organically, with record highs in key markets like Mexico and Brazil; total volumes up 0.8%.
- Normalized EBITDA increased 5.3% to $5.437 billion, margin stable at 35.6%; megabrands like Corona up 8.2% in revenue.
- Company reaffirmed FY 2026 EBITDA growth outlook of 4-8% in line with medium-term targets.
Q1 Earnings in Context: What Stands Out for BUD Investors
Anheuser-Busch InBev (BUD), the world's largest brewer, released its first quarter 2026 results on May 5, 2026. From what I see, these numbers offer valuable insights into global beer demand, especially as consumers shift toward premium and no-alcohol products. This report matters for investors because BUD continues to navigate U.S. market challenges stemming from prior brand issues, while leveraging megabrands like Corona and Stella Artois in emerging markets. Recent quarters have demonstrated resilience with consistent beats, though volume pressures in mature markets and currency volatility remain ongoing tests. The strong Q1 performance reinforces the company's execution on its premiumization strategy in a competitive landscape marked by inflation and regulatory hurdles.
Breaking Down the Reported Numbers
For Q1 2026 (January-March), Anheuser-Busch InBev (BUD) posted revenue of $15.267 billion, reflecting a 5.8% organic increase (12.0% reported) from $13.628 billion in Q1 2025. This topped consensus estimates of about $14.7 billion. Revenue per hectoliter (hl) rose 4.5%, propelled by megabrands (up 8.2%), no-alcohol beer (up 27%), and Beyond Beer (up 37%). Total volumes grew 0.8% to 136.4 million hl, with beer volumes up 1.2% to 118.5 million hl—beating expectations of a decline.
Normalized EBITDA climbed 5.3% to $5.437 billion from $4.855 billion, exceeding consensus growth of 2.6%, although the margin dipped 15 basis points to 35.6%. Underlying profit reached $1.923 billion, up from $1.606 billion. Underlying EPS surged 20.8% to a Q1 record $0.97 (8.8% constant currency) from $0.81, above forecasts near $0.91. Reported profit attributable to equity holders was $2.563 billion versus $2.148 billion.
I also checked this using Tickeron’s AI Screener to see how BUD stacks up against peers on key metrics like revenue growth and margins.
Discovering Opportunities with Tickeron’s AI Screener
In my own research, I rely on Tickeron’s AI Screener, an AI-powered tool for stock and ETF discovery. It lets me filter the market using technical patterns, fundamentals, trends, volatility, and AI-driven signals. With customizable options like industry, market cap, technical indicators, price patterns, and performance metrics, scanning thousands of assets becomes far more efficient than manual methods. This helps pinpoint trade ideas, trending stocks, breakout candidates, and hidden opportunities. I find it enhances my strategy—worth exploring if you're looking to streamline your screening process.
Initial Market Reaction and Sentiment
As of early trading on May 5, 2026, after the pre-market earnings release, BUD shares showed a mixed initial reaction amid broader market conditions. The stock had closed at $73.91 on May 4, down 2.18%, with pre-market indications varying. Investors seem positive on the earnings beat and volume growth, but cautious about margin pressure and non-beer volume declines. Sentiment centers on premium brand momentum offsetting U.S. softness, and analysts are likely to emphasize the reaffirmed outlook. I'm watching this closely as the day unfolds.
Looking Ahead: Guidance and Factors to Track
Anheuser-Busch InBev (BUD) reaffirmed its FY 2026 guidance, projecting normalized EBITDA growth of 4-8%, aligned with medium-term targets. In my view, this signals confidence in megabrand execution and category leadership despite headwinds. Key details include quarterly net finance costs of $190-220 million, average gross debt coupon around 4%, normalized effective tax rate of 26-28%, and net capital expenditure of $3.5-4.0 billion. The company has completed $1.4 billion of a $6 billion share buyback program as of May 1.
One thing that stands out is the need to monitor megabrands like Corona (up 16% outside home market) and innovations in no-alcohol and Beyond Beer for sustained revenue per hl growth. Beer volume trends in high-growth markets like Mexico and Brazil, versus declines in non-beer, will be critical. Upcoming catalysts include major sporting events like the Milano Cortina Winter Olympics activation and broader 2026 celebrations to boost demand.
Keep an eye on margin dynamics amid cost inflation, currency impacts (positive in Q1), and BEES platform expansion (GMV up 15% to $14.6 billion). Progress on debt reduction (net debt to EBITDA at 2.87x end-2025) and free cash flow generation remains essential for shareholder returns.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full Disclaimers and Limitations.
Contributor
Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.
BUD's RSI Indicator recovers from oversold territory
The RSI Indicator for BUD moved out of oversold territory on October 05, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 23 similar instances when the indicator left oversold territory. In 16 of the 23 cases the stock moved higher. This puts the odds of a move higher at 70%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 10 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +2.46% 3-day Advance, the price is estimated to grow further. Considering data from situations where BUD advanced for three days, in 186 of 331 cases, the price rose further within the following month. The odds of a continued upward trend are 56%.
BUD may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on September 17, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on BUD as a result. In 38 of 78 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 49%.
The Moving Average Convergence Divergence Histogram (MACD) for BUD turned negative on September 21, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 43 similar instances when the indicator turned negative. In 21 of the 43 cases the stock turned lower in the days that followed. This puts the odds of success at 49%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BUD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 50%.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating for company is 32 (best 1 - 100 worst), which means the company is slightly undervalued. The valuation of the company is based on a proprietary formula which takes into account a set of fundamentals and gives us an estimate of the price per share for the company. We then compare this estimate with the current price per share. As a result, this company is rated as undervalued in the industry. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.624) is normal, around the industry mean (2.040). P/E Ratio (16.616) is within average values for comparable stocks, (16.716). Projected Growth (PEG Ratio) (1.583) is also within normal values, averaging (2.082). Dividend Yield (0.018) settles around the average of (0.034) among similar stocks. BUD's P/S Ratio (2.564) is slightly higher than the industry average of (1.539).
The Tickeron PE Growth Rating for this company is 40 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 50 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 76, placing this stock slightly better than average.
The Tickeron Price Growth Rating for this company is 55 (best 1 - 100 worst), indicating steady price growth. BUD’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 68 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a holding company whose subsidiaries manufactures and distributes alcoholic and non-alcoholic beverages
Industry FoodMeatFishDairy
Advertisement